| pregnancy complications, neoplastic | Neoplasms occurring during the course of pregnancy, or pregnancy during the course of a neoplastic disease. (12 Dec 1998) |
|---|
| pregnancy complications | The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus. (12 Dec 1998) |
|---|---|
| pregnancy complications, cardiovascular | The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus. (12 Dec 1998) |
| pregnancy complications, haematologic | The co-occurrence of pregnancy and a blood disease. The haematologic disorder may be of the cells or coagulation elements of the blood but does not refer to deficiencies or excesses of various substances in the blood, such as hypercalcaemia or hypocalcaemia. It may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus. (12 Dec 1998) |
| pregnancy complications, infectious | Infections occurring during the course of pregnancy, or pregnancy during the course of an infectious disease. (12 Dec 1998) |
| pregnancy complications, parasitic | Parasitic diseases occurring during the course of pregnancy, or pregnancy during the course of a parasitic disease. Some of the more commonly co-occurring infections are amebiasis, malaria and toxoplasmosis. (12 Dec 1998) |
| gene expression regulation, neoplastic | Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. (12 Dec 1998) |
| cell transformation, neoplastic | Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. (12 Dec 1998) |
| neoplastic | <oncology, pathology> Pertaining to or like a neoplasm with new and abnormal growth, pertaining to neoplasia with the formation of a neoplasm. Origin: Gr. Plassein = to form (18 Nov 1997) |
| neoplastic arachnoiditis | Infiltration of subarachnoid space by neoplastic cells, typically medulloblastoma or metastatic carcinoma. Synonym: neoplastic arachnoiditis. (05 Mar 2000) |
| neoplastic endocrine-like syndromes | Endocrine syndromes due to hormone production by neoplasms of non-endocrine tissue, or by other than the usual endocrine tissues. They are often the first indication of a previously undetected neoplasm. (12 Dec 1998) |
| neoplastic meningitis | Infiltration of subarachnoid space by neoplastic cells, typically medulloblastoma or metastatic carcinoma. Synonym: neoplastic arachnoiditis. (05 Mar 2000) |
| neoplastic processes | The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity. (12 Dec 1998) |
| neoplastic syndromes, hereditary | The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumour tends to occur at an earlier than average age, individuals may have more than one primary tumour, the tumours may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance. (12 Dec 1998) |
| complications of ventriculo-peritoneal shunt | <radiology> Kinking, interruption, exit from peritoneal cavity with growth, through processus vaginalis to scrotum, CSFoma, mass effect exhibited on bowel gas pattern with malfunctioning shunt, lack of movement of shunt tip with positional or temporal change, perforation of hollow viscus (e.g., bowel or bladder) (12 Dec 1998) |
| postoperative complications | Disorders affecting patients after surgery. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. (12 Dec 1998) |